PLD
46
-4
SEE
53
3
NOC
56
2
ADI
49
-2
RRC
68
10
AAPL
40
-5
EXPD
40
-3
AAP
39
7
FITB
68
3
IRM
42
-4
MMC
61
-3
TSCO
53
-5
DFS
73
3
AON
60
-2
JNJ
39
-2
MRK
27
-3
CAG
31
-3
FOX
53
2
CA
25
3
PWR
72
-2
PLD
46
-4
SEE
53
3
NOC
56
2
ADI
49
-2
RRC
68
10
AAPL
40
-5
EXPD
40
-3
AAP
39
7
FITB
68
3
IRM
42
-4
MMC
61
-3
TSCO
53
-5
DFS
73
3
AON
60
-2
JNJ
39
-2
MRK
27
-3
CAG
31
-3
FOX
53
2
CA
25
3
PWR
72
-2
Financhill
Back

Summit Therapeutics Stock Predictions

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Buy
70

SMMT
Summit Therapeutics

Last Price:
20.75
Seasonality Move:
32.31%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Summit Therapeutics Stock Forecast

  • Over the next 52 weeks, Summit Therapeutics has on average historically risen by 131.3% based on the past 9 years of stock performance.
  • Summit Therapeutics has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Summit Therapeutics Stock Undervalued?
    The current Summit Therapeutics [SMMT] share price is $21.79. The Score for SMMT is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • SMMT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Summit Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Summit Therapeutics has on average historically risen by 131.3% based on the past 9 years of stock performance.

Summit Therapeutics Stock Rating

Buy
70
Summit Therapeutics (SMMT) is a Buy

Is Summit Therapeutics overpriced?

  • Summit Therapeutics has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Summit Therapeutics Stock Price History

Is SMMT stock going to rise?

  • The current trend is moderately bullish and SMMT is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
smmttx.com

52-Week Data

52-Week High:
33.89
52-Week Low:
1.79

Prediction Charts

Market Cap:
16.07B
Price in USD:
21.79
Volume:
2.13M
Beta:
-0.24

Technical Analysis

SMA50:
20.73
SMA100:
15.38
SMA200:
10.05
52-Wk Change:
1043.83%

Stock Predictions

  • Is Summit Therapeutics stock public?
    Yes, Summit Therapeutics is a publicly traded company.
  • What is the Summit Therapeutics stock quote today?
    The Summit Therapeutics stock price is 21.79 USD today.
  • How to buy Summit Therapeutics stock online?
    You can buy Summit Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-23 20.41 20.03 20.57 19.34
Oct-24 20.06 19.46 20.75 19.43
Oct-25 19.69 21.26 21.54 19.68
Oct-28 21.41 22.24 22.90 21.26
Oct-29 21.76 21.83 22.30 21.11
Oct-30 21.00 18.65 21.18 18.60
Oct-31 18.75 18.59 19.42 18.10
Nov-1 18.98 18.99 19.77 18.61
Nov-4 19.41 19.96 20.56 18.80
Nov-5 20.10 20.39 20.55 19.70
Nov-6 20.16 20.89 20.96 19.01
Nov-7 21.19 21.10 21.68 20.26
Nov-8 21.21 21.41 21.83 20.72
Nov-11 21.90 21.79 22.53 21.42

Summit Therapeutics Earnings

Summit Therapeutics Earnings Report: Per Share Summit Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Summit Therapeutics Forecast Revenue Growth

Summit Therapeutics Stock Analysis: Historical quarterly revenues per share for Summit Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and a decrease next year of $0.08 per share.

* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.